Home

Lineage, Inc. - Common Stock (LINE)

58.65
0.00 (0.00%)

Lineage, Inc. is a biotech company focused on advancing regenerative medicine and developing therapeutic solutions for patients with degenerative diseases and injuries

The company utilizes innovative technologies, including stem cell research and tissue engineering, to create treatments aimed at restoring function and improving quality of life. Through its research and development efforts, Lineage seeks to bring groundbreaking therapies to market, addressing unmet medical needs in various fields such as ophthalmology, neurology, and orthopedics. By leveraging scientific advancements and collaborative partnerships, Lineage continues to work towards its mission of transforming medicine and enhancing patient outcomes.

SummaryNewsPress ReleasesChartHistoricalFAQ